The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ROSELLA: A phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in patients with platinum-resistant ovarian cancer (GOG-3073, ENGOT-ov72).
 
Alexander Olawaiye
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo/Lilly; Eisai; Genentech; GlaxoSmithKline; Novocure; tesaro
 
Laurence Gladieff
Consulting or Advisory Role - GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology
 
Lucy Gilbert
Honoraria - GlaxoSmithKline; Merck; Repare Therapeutics
Consulting or Advisory Role - Corcept Therapeutics; Eisai; GlaxoSmithKline; Immunogen; Kora Healthcare; Merck
Research Funding - Alkermes (Inst); Ascendis Pharma (Inst); AstraZeneca (Inst); Corcept Therapeutics (Inst); Esperas Pharma (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Immunogen (Inst); IMV (Inst); K-Group Beta (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Mersana (Inst); Novocure (Inst); OncoQuest (Inst); Repare Therapeutics (Inst); Roche (Inst); Seagen (Inst); Shattuck Labs (Inst); Sutro BioPharma Inc (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Corcept Therapeutics; Eisai; EndomEra; GlaxoSmithKline; GOG Foundation; Merck; Zentalis
 
Jae-Weon Kim
No Relationships to Disclose
 
Mariana Scaranti
Employment - DASA Oncologia
Leadership - DASA Oncologia
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Libbs; MSD Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; GlaxoSmithKline; MSD Oncology
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; MSD Oncology
Research Funding - AstraZeneca (Inst); Corcept Therapeutics (Inst); Libbs (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; MSD Oncology
 
Vanda Salutari
Consulting or Advisory Role - Eisai/MSD; ImmunoGen; MSD Oncology
Speakers' Bureau - AstraZeneca; Eisai/MSD; GlaxoSmithKline; MSD Oncology
Travel, Accommodations, Expenses - Menarini Group; MSD Oncology
 
Elizabeth Hopp
Employment - GE Healthcare (I)
Stock and Other Ownership Interests - GE Healthcare (I)
Consulting or Advisory Role - Immunogen
 
Linda Mileshkin
Honoraria - GlaxoSmithKline; The Limbic
Research Funding - BeiGene (Inst)
Travel, Accommodations, Expenses - Roche
Other Relationship - Roche
 
Alix Devaux
Speakers' Bureau - GlaxoSmithKline
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Novartis
 
Michael McCollum
Employment - Virginia Oncology Associates
Research Funding - Genentech (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Seagen (Inst)
 
Ana Oaknin
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo; Debiopharm Group; Deciphera; Eisai; Exelixis; Genmab; GlaxoSmithKline; Immunogen; ITeos Therapeutics; Merck Sharp & Dohme; Mersana; Myriad Genetics; Novocure; OncoXerna Therapeutics; PharmaMar; Regeneron; Roche; Seagen / Pfizer; Shattuck Labs; Sutro Biopharma; TORL Therapuetics; Zentalis; Zymeworks
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Immunogen; MSD; Roche
Research Funding - Abbvie (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); PharmaMar (Inst); Regeneron (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche
 
Aliza Leiser
No Relationships to Disclose
 
Nicoletta Colombo
Employment - Sarepta Therapeutics (I)
Honoraria - AstraZeneca; BioNTech; Clovis Oncology; Eisai; Gilead Sciences; GlaxoSmithKline; Immunogen; Incyte; mersana; MSD Oncology; Novocure; Nuvation Bio; OCXERNA; Pieris Pharmaceuticals; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Immunogen; mersana; MSD Oncology; Novocure; Nuvation Bio; OCXERNA; Pieris Pharmaceuticals; Roche/Genentech
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; MSD Oncology
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Corcept Therapeutics; GlaxoSmithKline
 
Andrew Clamp
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - GlaxoSmithKline
Research Funding - Advenchen Laboratories (Inst); Alkermes (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); Eisai (Inst); Immunogen (Inst); Merck (Inst); MorphoSys (Inst); Pfizer (Inst); Verastem (Inst)
 
Boglarka Balazs
No Relationships to Disclose
 
Giuseppa Scandurra
No Relationships to Disclose
 
Emilie Kaczmarek
No Relationships to Disclose
 
Hristina Pashova
Employment - Corcept Therapeutics
Stock and Other Ownership Interests - Corcept Therapeutics
 
Sachin Pai
Employment - Corcept Therapeutics Inc.; Erasca, Inc
Stock and Other Ownership Interests - Corcept Therapeutics Inc.; Erasca, Inc
 
Domenica Lorusso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo/Lilly; Genmab; GlaxoSmithKline; Immunogen; MSD; Novartis; Novocure; Oncoinvest; PharmaMar; Seagen; Sutro Biopharma
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; ImmunoGen; MSD; Seagen
Research Funding - Alkermes (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Incyte (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Pharma& (Inst); PharmaMar (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Menarini
(OPTIONAL) Uncompensated Relationships - ENGOT; Gynecological Cancer InterGroup; MITO